Marquette Asset Management, LLC Lumos Pharma, Inc. Transaction History

Marquette Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$2.63 - $3.49 $14,012 - $18,594	-5,328 Reduced 17.14%	25,760 $85,000
Q1 2023 May 01, 2023	BUY	$3.16 - $4.0 $31,814 - $40,272	10,068 Added 47.9%	31,088 $102,000
Q4 2022 Jan 12, 2023	BUY	$3.05 - $9.52 $23,500 - $73,351	7,705 Added 57.87%	21,020 $0
Q4 2021 Jan 19, 2022	BUY	$6.84 - $10.04 $554 - $813	81 Added 0.61%	13,315 $92,000
Q3 2021 Oct 12, 2021	BUY	$7.36 - $11.36 $31,758 - $49,018	4,315 Added 48.38%	13,234 $126,000
Q2 2021 Jul 19, 2021	BUY	$9.75 - $13.44 $86,960 - $119,871	8,919 New	8,919 $89,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.